No Data
No Data
Subdued Growth No Barrier To Ascentage Pharma Group International (HKG:6855) With Shares Advancing 26%
YAS Pharmaceuticals-B (06855) further grants awards based on the 2018 Restricted Share Unit Plan, 2021 Restricted Share Unit Plan, and 2022 Restricted Share Unit Plan.
Yasheng Pharmaceutical-B (06855) announced in a statement that as of the date of this announcement, the board of directors has determined the terms and conditions of the 2018 Restricted Stock Incentive Plan...
Upgrade: Analysts Just Made A Massive Increase To Their Ascentage Pharma Group International (HKG:6855) Forecasts
The expected interest rate cut by the U.S. Federal Reserve boosts the Hong Kong stock market, with real estate and golden industrial concept performing well.
①The expectation of a Fed rate cut is strengthening, which sectors are expected to benefit? ②Why did xpeng stock soar today?
Yasheng Pharmaceuticals has also landed | JIANZHI Research
One step closer to regular profitability.
Ascentage Pharma Turns to H1 Profit as Revenue Balloons 477%; Shares Jump 4%
No Data